Annexin A2 Regulates Surfactant Dysfunction During Injurious Ventilation

Area of Science:

• Pulmonary medicine
• Molecular biology
• Biochemistry

Background:

• Acute Respiratory Distress Syndrome (ARDS) causes respiratory failure, often necessitating mechanical ventilation.
• Mechanical ventilation can lead to ventilator-induced lung injury (VILI), exacerbating lung dysfunction.
• The mechanisms underlying surfactant dysfunction in ARDS and VILI are not fully understood.

Purpose of the Study:

• To investigate the role of Annexin A2 (AnxA2) in regulating pulmonary surfactant function during injurious ventilation.
• To determine if AnxA2 deficiency impacts lung mechanics and surfactant properties following VILI.

Main Methods:

• Comparison of lung mechanics and surfactant function between wild-type and AnxA2 knockout (AnxA2-/-) mice subjected to injurious mechanical ventilation.
• Analysis of lung stiffness, pulmonary barrier permeability, and inflammation.
• Assessment of surfactant surface tension-lowering properties and composition, specifically focusing on 1-palmitoyl-2-oleoylphosphatidylglycerol (POPG).

Main Results:

• AnxA2-/- mice exhibited increased lung stiffness after VILI compared to wild-type mice.
• Surfactant isolated from AnxA2-/- mice showed impaired surface tension-lowering capacity.
• A reduction in POPG content was observed in surfactant from AnxA2-/- mice, correlating with altered phase transitions during compression.

Conclusions:

• Annexin A2 plays a critical role in maintaining pulmonary surfactant composition and function during injurious ventilation.
• AnxA2 deficiency leads to lung stiffening and surfactant dysfunction in the context of VILI.
• Targeting Annexin A2 may offer a novel therapeutic strategy to prevent surfactant dysfunction in mechanically ventilated ARDS patients.